[Standardized management of targeted drugs for rheumatism].

In recent years, with the continuous in-depth research on the pathogenesis of rheumatism and the rapid development of biopharmaceutical technology, the development of targeted drugs for rheumatism is in full swing. In order to better standardize the diagnosis and treatment of rheumatism and the rational application of targeted drugs, the Chinese Rheumatology Association will introduce the targeted drugs for rheumatism that have been approved by the China National Medical Products Administration so far, and provide clinicians with standardized diagnosis and treatment reference.近年来，随着对风湿病发病机制研究的不断深入，及生物制药技术的迅猛发展，风湿病的靶向药物发展如火如荼。中华医学会风湿病学分会为更好地规范风湿病诊疗及靶向药物的合理应用，就目前已取得中国国家药品监督管理局批准应用的风湿病靶向药物逐一介绍，为临床医生规范使用提供参考。.